Abstract: . . .  curcumin, 23% demethoxycurcumin and 2% bisdemethoxycurcumin, which is consistent with other commercial curcuminoid products. However, the curcu- min activity as measured by HPLC area count for a Table 2: Serum curcumin levels in ng/ml for two subjects Dose Baseline One hour Two hour Four hour 10000 mg approx. 6.0 30.4 39.5 50.5 12000 mg approx. trace 29.7 57.6 51.2 Page 4 BMC Complementary and Alternative Medicine 2006, 6 :10 http://www.biomedcentral.com/1472-6882/6/10 Page 4 of 4 (page number not for citation purposes) weighed portion of capsular content was 66% less than an equivalent weighed portion of a previously supplied, pure curcumin powder (unpublished data). Thus, curcumin bioavailability in humans and biologic activity might dif- . . .
. . .  curcumin, 23% demethoxycurcumin and 2% bisdemethoxycurcumin, which is consistent with other commercial curcuminoid products. However, the curcu- min activity as measured by HPLC area count for a Table 2: Serum curcumin levels in ng/ml for two subjects Dose Baseline One hour Two hour Four hour 10000 mg approx. 6.0 30.4 39.5 50.5 12000 mg approx. trace 29.7 57.6 51.2 Page 4 BMC Complementary and Alternative Medicine 2006, 6 :10 http://www.biomedcentral.com/1472-6882/6/10 Page 4 of 4 (page number not for citation purposes) weighed portion of capsular content was 66% less than an equivalent weighed portion of a previously supplied, pure curcumin powder (unpublished data). Thus, curcumin bioavailability in humans and biologic activity might dif- fer . . .
. . .  mice. Drug Metab Dispos 1999, 27(4): 486-494. 24. Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP, Gescher A: Charac- terization of metabolites of the chemopreventive agent cur- cumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester- induced prostaglandin E2 production. Cancer Res 2001, 61(3): 1058-1064. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-6882/6/10/prepub  . . .
. . .  demethoxycurcumin and 2% bisdemethoxycurcumin, which is consistent with other commercial curcuminoid products. However, the curcu- min activity as measured by HPLC area count for a Table 2: Serum curcumin levels in ng/ml for two subjects Dose Baseline One hour Two hour Four hour 10000 mg approx. 6.0 30.4 39.5 50.5 12000 mg approx. trace 29.7 57.6 51.2 Page 4 BMC Complementary and Alternative Medicine 2006, 6 :10 http://www.biomedcentral.com/1472-6882/6/10 Page 4 of 4 (page number not for citation purposes) weighed portion of capsular content was 66% less than an equivalent weighed portion of a previously supplied, pure curcumin powder (unpublished data). Thus, curcumin bioavailability in humans and biologic activity might dif- fer based upon the formulation . . .
--3000,4,375,3123,20028